期刊文献+

血管内皮功能与2型糖尿病下肢血管病变的关系 被引量:4

The relationship between vascular endothelial function and lower limb angiopathy in type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨2型糖尿病(T2DM)下肢血管病变(LLA)与血管内皮功能的关系。方法 71例T2DM患者通过彩色多普勒超声确诊的LLA严重程度分为:无LLA 26例、轻度17例、中度15例、重度13例;另选30名健康人为正常对照(NC)组。采用酶联免疫吸附双抗体夹心法,检测代表血管内皮功能的血浆血管性假血友病因子(vWF)和单核细胞趋化蛋白-1(MCP-1)水平。结果血浆MCP-1、vWF水平,糖尿病无LLA组明显高于NC组,有LLA组明显高于无LLA组,以及各LLA亚组间比较差异均有统计学意义(P均<0.01)。各LLA亚组下肢血管评分与血浆MCP-1(r=0.926,P<0.01)、vWF(r=0.942,P<0.01)水平正相关。结论血管内皮功能影响下肢血管病变。 Objective To investigate the relationship between vascular endothelial function and lower limb angiopathy(LLA) in type 2 diabetes mellitus. Methods 71 hospitalized T2DM patients were divided into four groups: 26 patients (group A) without LLA; 17 patients (group B) with light degree of LLA; 15 patients (group C) with middle LLA; 13 patients (group D) with critical LLA by color Doppler ultrasound. Normal control group were 30 subjects (NC group). The plasma von Willebrand factor(vWF) and monocyte chemoattractant protein 1 (MCP-1) were determined by ELISA. Results The plasma MCP-1 and vWF level were higher in group A than in NC group, and higher in group B,C,and D than in group A(all P〈0. 01). There were differences among groups B,C,D in MCP-1 and vWF (P〈0.01). Scores of LLA were positively correlated with MCP 1 (r= 0. 926, P〈0. 01) and vWF(r= 0. 942, P〈 0. 01). Conclusions The MCP-1 and vWF levels show a relationship with lower limb angiopathy in type 2 diabetes patients.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2010年第8期604-606,共3页 Chinese Journal of Diabetes
关键词 糖尿病 2型 下肢血管病变 单核细胞趋化蛋白-1 血管性假血友病因子 Diabetes mellitus, type 2 Lower limb angiopathy Monocyte chemoattractant protein-1 yon Willebrand factor
  • 相关文献

参考文献7

二级参考文献38

  • 1余秀华,李黎,施红,徐爱芬,张宏.彩色多普勒超声对糖尿病下肢动脉病变的观察[J].东南国防医药,2003,5(4):279-280. 被引量:6
  • 2吴国新,阮长耿.血小板颗粒膜蛋白研究进展[J].中华血液学杂志,1994,15(3):162-164. 被引量:231
  • 3张强.血小板GPⅡb/Ⅲa及其拮抗剂在冠心病临床实践的应用[J].心血管病学进展,1996,17(6):328-331. 被引量:2
  • 4谢瑞芹,王凤飞,都本洁,李荣华,张玉华,宋文杰,王翠霞.冠心病和糖尿病患者血栓前状态的检测[J].临床心血管病杂志,1997,13(2):85-87. 被引量:18
  • 5Williams SB,Goldfine AB,Timimi FK,et al.Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo[J].Circulation,1998,97(17):1695-1701.
  • 6Raitakari OT,Celermajer DS.Flow-mediated dilatation[J].Br J Clin Pharmacol,2000,50(5):397-404.
  • 7Maeso R,Rodrigo E,Munoz-Garcia R,et al.Factors involved in the effects of losartan on endothelial dysfunction induced by aging in SHR[J].Kidney Int,1998,68(Suppl):30-35.
  • 8Tesfamariam B.Free radicals in diabetic endothelial cell dysfunction[J].Free Radic Biol Med,1994,16(3):383-391.
  • 9Ohara Y,Sayegh HS,Yamin JJ,et al.Regulation of endothelial constitutive nitric oxide synthase by protein kinase C[J].Hypertension,1995,25(3):415-520.
  • 10Nishio E,Watanabe Y.Glucose-induced down-regulation of NO production and inducible NOS expression in cultured rat aortic vascular smooth muscle cells:role of protein kinase C[J].Biochem Biophys Res Commun,1996,229(3):857-863.

共引文献42

同被引文献71

  • 1张雪莲,傅汉菁,潘素芳.糖尿病慢性大血管并发症与vWF的关系[J].首都医科大学学报,2004,25(4):488-492. 被引量:8
  • 2Navarro S,Ricart JM,Medina P,et al.Activated protein C levels in Behcet's disease and risk of venous thrombosis[J].Br J Haematol,2004,126(4):550.
  • 3M(a)kimattila S,Virkamki A,Groop PH,et al.Chronic hyperglycaemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus[J].Circulation,1996,94(6):1276.
  • 4Blann AD,Dobrotova M,Kubisz P,et al.Von willebrand factor,soluble P-selectin,tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis[J].Thromb Haemost,1995,74(2):626.
  • 5Karamanos B,Porta M,Songini M,et al.Different risk factors of microangiopathy in patients with type 1 diabetes mellitus of short versus long duration.The EURODIAB IDDM Complications study[J].Diabetologia,2000,43(3):348.
  • 6Pedrinelli R,Giampietro O,Carmassi F,et al.Microalbuminuria and endothelial dysfunction in essential hypertension[J].Lancet,1994,344(8914):14.
  • 7Kimberlee B,Hobizal,Dane K. Diabetic foot infections:cur-rent concept Review[J].Diabetic Foot & Ankle,2012,(18):409-416.
  • 8Lipsky BA,Berend AR,Comia PB. 2012 Infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infectionsa[J].Clinical Infectious Disea-ses,2012,(12):132-173.
  • 9Attan R,Nayak D. High levels of plasma malondialdehyde,Pro-tein carbonyl,and fibrinogen have prognostic potential in predict poor outcomes in patient with diabetic foot wound:a preliminary communication[J].Low Extrem Wounds,2008,(04):198-203.
  • 10De Moerloose P,Neerman AM. Congenital fibrinogen disorders[J].{H}Seminars in Thrombosis and Hemostasis,2009,(04):356-366.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部